Neurogene Inc. (NGNE) Insider Trading
Directors, officers and holders of more than 10% of NGNE report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 56 transactions on file: 2 with code P, 19 with code S and 29 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 22, 2026 | McMinn Rachel | Chief Executive Officer | M Exercise | 756 | $25.32 | $19,142 |
| Sep 22, 2026 | McMinn Rachel | Chief Executive Officer | M Exercise | 756 | Not measured | Not measured |
| Jul 7, 2026 | Cvijic Christine Mikail | President and CFO | S Sale | 4,200 | $36.13 | $151,763 |
| Jul 6, 2026 | Cvijic Christine Mikail | President and CFO | S Sale | 600 | $36.02 | $21,613 |
| Jul 2, 2026 | Cvijic Christine Mikail | President and CFO | S Sale | 1,530 | $35.23 | $53,897 |
| Jul 2, 2026 | Cvijic Christine Mikail | President and CFO | S Sale | 2,531 | $34.58 | $87,519 |
| Jul 1, 2026 | Cvijic Christine Mikail | President and CFO | S Sale | 739 | $34.06 | $25,170 |
| May 6, 2026 | Cvijic Christine Mikail | President and CFO | S Sale | 4,800 | $30.07 | $144,351 |
| May 6, 2026 | Cvijic Christine Mikail | President and CFO | S Sale | 4,800 | $32.44 | $155,692 |
| May 5, 2026 | Shafer Christina | Chief Commercial Officer | A Award | 120,000 | Not measured | Not measured |
| Mar 26, 2026 | Cvijic Christine Mikail | President and CFO | S Sale | 2,558 | $21.62 | $55,316 |
| Mar 26, 2026 | Jordan Julie | Chief Medical Officer | S Sale | 828 | $21.89 | $18,128 |
| Mar 26, 2026 | McMinn Rachel | Chief Executive Officer | S Sale | 3,352 | $22.07 | $73,995 |
| Mar 13, 2026 | Cobb Stuart | Chief Scientific Officer | S Sale | 3,991 | $20.41 | $81,456 |
| Mar 13, 2026 | Cobb Stuart | Chief Scientific Officer | S Sale | 2,658 | $21.34 | $56,722 |
| Mar 13, 2026 | Cobb Stuart | Chief Scientific Officer | S Sale | 148 | $22.08 | $3,268 |
| Mar 13, 2026 | Cvijic Christine Mikail | President and CFO | S Sale | 2,387 | $20.42 | $48,748 |
| Mar 13, 2026 | Cvijic Christine Mikail | President and CFO | S Sale | 1,395 | $21.25 | $29,637 |
| Mar 13, 2026 | Cvijic Christine Mikail | President and CFO | S Sale | 263 | $22.02 | $5,791 |
| Feb 27, 2026 | Cvijic Christine Mikail | President and CFO | S Sale | 4,800 | $25.11 | $120,526 |
| Feb 20, 2026 | Noonberg Sarah B. | Director | A Award | 12,050 | Not measured | Not measured |
| Feb 20, 2026 | Cobb Stuart | Chief Scientific Officer | A Award | 16,500 | Not measured | Not measured |
| Feb 20, 2026 | Jordan Julie | Chief Medical Officer | A Award | 4,900 | Not measured | Not measured |
| Feb 20, 2026 | Cvijic Christine Mikail | President and CFO | A Award | 22,000 | Not measured | Not measured |
| Feb 20, 2026 | McMinn Rachel | Chief Executive Officer | A Award | 25,900 | Not measured | Not measured |
| Feb 20, 2026 | Jordan Julie | Chief Medical Officer | A Award | 29,600 | Not measured | Not measured |
| Feb 20, 2026 | Cvijic Christine Mikail | President and CFO | A Award | 131,900 | Not measured | Not measured |
| Feb 20, 2026 | McMinn Rachel | Chief Executive Officer | A Award | 155,100 | Not measured | Not measured |
| Feb 20, 2026 | PALEKAR ROHAN | Director | A Award | 12,050 | Not measured | Not measured |
| Feb 20, 2026 | BAFFI ROBERT | Director | A Award | 12,050 | Not measured | Not measured |
| Feb 20, 2026 | Freedland Cory S. | Director | A Award | 12,050 | Not measured | Not measured |
| Feb 20, 2026 | Woods Keith | Director | A Award | 12,050 | Not measured | Not measured |
| Jun 12, 2025 | BAFFI ROBERT | Director | A Award | 12,050 | Not measured | Not measured |
| Jun 12, 2025 | Noonberg Sarah B. | Director | A Award | 12,050 | Not measured | Not measured |
| Jun 12, 2025 | PALEKAR ROHAN | Director | A Award | 12,050 | Not measured | Not measured |
| Jun 12, 2025 | Freedland Cory S. | Director | A Award | 12,050 | Not measured | Not measured |
| Jun 12, 2025 | Woods Keith | Director | A Award | 12,050 | Not measured | Not measured |
| Jun 12, 2025 | Woods Robert Keith | Director | A Award | 12,050 | Not measured | Not measured |
| May 14, 2025 | Cobb Stuart | Chief Scientific Officer | S Sale | 6,797 | $15.15 | $103,003 |
| Mar 26, 2025 | McMinn Rachel | Chief Executive Officer | A Award | 23,900 | Not measured | Not measured |
| Mar 26, 2025 | Cobb Stuart | Chief Scientific Officer | A Award | 42,900 | Not measured | Not measured |
| Mar 26, 2025 | Cvijic Christine Mikail | President and CFO | A Award | 122,000 | Not measured | Not measured |
| Mar 26, 2025 | Jordan Julie | Chief Medical Officer | A Award | 50,300 | Not measured | Not measured |
| Mar 26, 2025 | McMinn Rachel | Chief Executive Officer | A Award | 143,500 | Not measured | Not measured |
| Mar 26, 2025 | Cvijic Christine Mikail | President and CFO | A Award | 20,300 | Not measured | Not measured |
| Mar 26, 2025 | Cobb Stuart | Chief Scientific Officer | A Award | 7,200 | Not measured | Not measured |
| Mar 26, 2025 | Jordan Julie | Chief Medical Officer | A Award | 8,400 | Not measured | Not measured |
| Mar 13, 2025 | Cvijic Christine Mikail | President and CFO | S Sale | 4,501 | $16.94 | $76,247 |
| Nov 26, 2024 | Samsara BioCapital GP, LLC | 10% Owner | P Purchase | 20,748 | $24.91 | $516,833 |
| Nov 26, 2024 | Samsara BioCapital GP, LLC | 10% Owner | P Purchase | 10,803 | $26.01 | $280,986 |
The full Form 4 history is on the NGNE company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.